Symptomatic, pharmacological treatment of myasthenia gravis.

Authors

DOI:

https://doi.org/10.17161/rrnmf.v4i3.19548

Keywords:

myasthenia gravis, symptomatic treatment, pyridostigmine, amifampridine, adrenergic agonist

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

Downloads

Published

2023-08-29

Issue

Vol. 4 No. 3 (2023): Proceedings of the MGFA International Conference

Section

MGFA International Conference Proceedings

License

Copyright (c) 2023 Linda Remijn-Nelissen, Wisse R. Bakker, Teun van Gelder, Martijn R. Tannemaat, Jan J.G.M. Verschuuren

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Remijn-Nelissen, L., Bakker, W., van Gelder, T., Tannemaat, M., & Verschuuren, J. (2023). Symptomatic, pharmacological treatment of myasthenia gravis. RRNMF Neuromuscular Journal, 4(3). https://doi.org/10.17161/rrnmf.v4i3.19548